In the presented study, the expression of MMP2, MMP9 and TIMP1 genes was assessed in the blood of NSCLC patients at three time points, before the tumor removal surgery, 100 days after surgery and one year after surgery, and in the tumor tissue. This evidence concerns the gene TIMP1 and non-small cell lung carcinoma.